Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment

References

• Nogueira E, Gomes AC, Preto A, et al. Folate-targeted nanoparticles for rheumatoid arthritis therapy. Nanomedicine. 2016;12:1113–1126.
   PubMed Web of Science ®Google Scholar
• Van Vollenhoven RF. Sex differences in rheumatoid arthritis: more than meets the eye. BMC Med. 2009;7:12.
   PubMed Web of Science ®Google Scholar
• Kinne RW, Bräuer R, Stuhlmüller B, et al. Macrophages in rheumatoid arthritis. Arthritis Res. 2000;2:189.
   PubMedGoogle Scholar
• Stupack DG, Storgard CM, Cheresh DA. A role for angiogenesis in rheumatoid arthritis. Braz J Med Biol Res. 1999;32:573–581.
   PubMed Web of Science ®Google Scholar
• Medich JR, Kupper H, Kent JD, et al. Uses and compositions for treatment of rheumatoid arthritis. United States patent application US 11/800,531; 2007.
   Google Scholar
• Yuan F, Quan LD, Cui L, et al. Development of macromolecular prodrug for rheumatoid arthritis. Adv Drug Deliv Rev. 2012;64:1205–1219.
   PubMed Web of Science ®Google Scholar
• Gouveia VM, Lima SC, Nunes C, et al. Non-biologic nanodelivery therapies for rheumatoid arthritis. J Biomed Nanotechnol. 2015;11:1701–1721.
   PubMed Web of Science ®Google Scholar
• Shaji JE, Lal MA. Nanocarriers for targeting in inflammation. Asian J Pharm Clin Res. 2013;6:3–12.
   Google Scholar
• Dolati S, Sadreddini S, Rostamzadeh D, et al. Utilization of nanoparticle technology in rheumatoid arthritis treatment. Biomed Pharmacother. 2016;80:30–41.
   PubMed Web of Science ®Google Scholar
• Cao J, Naeem M, Noh JK, et al. Dexamethasone phosphate-loaded folate-conjugated polymeric nanoparticles for selective delivery to activated macrophages and suppression of inflammatory responses. Macromol Res. 2015;23:485–492.
   Web of Science ®Google Scholar
• Nogueira E, Lager F, Le Roux D, et al. Enhancing methotrexate tolerance with folate tagged liposomes in arthritic mice. J Biomed Nanotechnol. 2015;11:2243–2252.
   PubMed Web of Science ®Google Scholar
• Qi R, Majoros I, Misra AC, et al. Folate receptor-targeted dendrimer-methotrexate conjugate for inflammatory arthritis. J Biomed Nanotechnol. 2015;11:1431–1441.
   PubMed Web of Science ®Google Scholar
• Chandrasekar D, Sistla R, Ahmad FJ, et al. Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery. J Biomed Mater Res. 2007;82:92–103.
   Web of Science ®Google Scholar
• Bilthariya U, Jain N, Rajoriya V, et al. Folate-conjugated albumin nanoparticles for rheumatoid arthritis-targeted delivery of etoricoxib. Drug Dev Ind Pharm. 2015;41:95–104.
   PubMed Web of Science ®Google Scholar
• Yang M, Ding J, Zhang Y, et al. Activated macrophage-targeted dextran–methotrexate/folate conjugate prevents deterioration of collagen-induced arthritis in mice. J Mater Chem B. 2016;4:2102–2113.
   PubMed Web of Science ®Google Scholar
• Heo R, Park JS, Jang HJ, et al. Hyaluronan nanoparticles bearing γ-secretase inhibitor: in vivo therapeutic effects on rheumatoid arthritis. J Control Release. 2014;192:295–300.
   PubMed Web of Science ®Google Scholar
• Alam MM, Han HS, Sung S, et al. Endogenous inspired biomineral-installed hyaluronan nanoparticles as pH-responsive carrier of methotrexate for rheumatoid arthritis. J Control Release. 2017;252:62–72.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Chae SY, Jin CH, et al. Ionic complex systems based on hyaluronic acid and PEGylatedTNF-related apoptosis-inducing ligand for treatment of rheumatoid arthritis. Biomaterials. 2010;31:9057–9064.
   PubMed Web of Science ®Google Scholar
• Kim SH, Kim JH, You DG, et al. Self-assembled dextran sulphate nanoparticles for targeting rheumatoid arthritis. Chem Commun. 2013;49:10349–10351.
   PubMed Web of Science ®Google Scholar
• Heo R, You DG, Um W, et al. Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis. Biomaterials. 2017;131:15–26.
   PubMed Web of Science ®Google Scholar
• Put S, Schoonooghe S, Devoogdt N, et al. SPECT imaging of joint inflammation with Nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis. J Nucl Med. 2013;54:807–814.
   Google Scholar
• Maruotti N, Cantatore FP, Crivellato E, et al. Angiogenesis in rheumatoid arthritis. Histol Histopathol. 2006;21:557–566.
   PubMed Web of Science ®Google Scholar
• Temming K, Lacombe M, van der Hoeven P, et al. Delivery of the p38 MAP kinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology. Bioconjug Chem. 2006;17:1246–1255.
   PubMed Web of Science ®Google Scholar
• Koning GA, Schiffelers RM, Wauben MH, et al. Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. Arthritis Rheum. 2006;54:1198–1208.
   PubMed Web of Science ®Google Scholar
• Gerlag DM, Borges E, Tak PP, et al. Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Res. 2001;3:357–361.
   PubMedGoogle Scholar
• Mi Z, Mai J, Lu X, et al. Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. Mol Ther. 2000;2:339–347.
   PubMed Web of Science ®Google Scholar
• Mi Z, Lu X, Mai JC, et al. Identification of a synovial fibroblast-specific protein transduction domain for delivery of apoptotic agents to hyperplastic synovium. Mol Ther. 2003;8:295–305.
   PubMed Web of Science ®Google Scholar
• Vanniasinghe AS, Manolios N, Schibeci S, et al. Targeting fibroblast-like synovial cells at sites of inflammation with peptide targeted liposomes results in inhibition of experimental arthritis. Clin Immunol. 2014;151:43–54.
   PubMed Web of Science ®Google Scholar
• Koo OM, Rubinstein I, Onyüksel H. Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis. Pharm Res. 2011;28:776–787.
   PubMed Web of Science ®Google Scholar
• Etzerodt A, Maniecki MB, Graversen JH, et al. Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163. J Control Release. 2012;160:72–80.
   PubMed Web of Science ®Google Scholar
• Bédouet L, Moine L, Pascale F, et al. Synthesis of hydrophilic intra-articular microspheres conjugated to ibuprofen and evaluation of anti-inflammatory activity on articular explants. Int J Pharm. 2014;459:51–61.
   PubMed Web of Science ®Google Scholar
• Qi X, Qin X, Yang R, et al. Intra-articular administration of chitosan thermosensitive in situ hydrogels combined with diclofenac sodium-loaded alginate microspheres. J Pharm Sci. 2016;105:122–130.
   PubMed Web of Science ®Google Scholar
• Thakkar H, Kumar Sharma R, Murthy RS. Enhanced retention of celecoxib-loaded solid lipid nanoparticles after intra-articular administration. Drugs R D. 2007;8:275–285.
   PubMedGoogle Scholar
• Saadat E, Shakor N, Gholami M, et al. Hyaluronic acid based micelle for articular delivery of triamcinolone, preparation, in vitro and in vivo evaluation. Int J Pharm. 2015;489:218–225.
   PubMed Web of Science ®Google Scholar
• Ryan SM, McMorrow J, Umerska A, et al. An intra-articular salmon calcitonin-based nanocomplex reduces experimental inflammatory arthritis. J Control Release. 2013;167:120–129.
   PubMed Web of Science ®Google Scholar
• Zhang JX, Yan MQ, Li XH, et al. Local delivery of indomethacin to arthritis-bearing rats through polymeric micelles based on amphiphilic polyphosphazenes. Pharm Res. 2007;24:1944–1953.
   PubMed Web of Science ®Google Scholar
• Russo E, Gaglianone N, Baldassari S, et al. Chitosan-clodronate nanoparticles loaded in poloxamer gel for intra-articular administration. Colloids Surf B Biointerfaces. 2016;143:88–96.
   PubMed Web of Science ®Google Scholar
• Gomes A, Datta P, Sengupta J, et al. Evaluation of anti-arthritic property of methotrexate conjugated gold nanoparticle on experimental animal models. J Nanopharm Drug Deliv. 2013;1:206–211.
   Google Scholar
• Lee H, Lee MY, Bhang SH, et al. Hyaluronate-gold nanoparticle/tocilizumab complex for the treatment of rheumatoid arthritis. ACS Nano. 2014;8:4790–4798.
   PubMed Web of Science ®Google Scholar
• Lima SA, Reis S. Temperature-responsive polymeric nanospheres containing methotrexate and gold nanoparticles: a multi-drug system for theranostic in rheumatoid arthritis. Colloids Surf B Biointerfaces. 2015;133:378–387.
   PubMed Web of Science ®Google Scholar
• Lee SM, Kim HJ, Ha YJ, et al. Targeted chemo-photothermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles. ACS Nano. 2013;7:50–57.
   PubMed Web of Science ®Google Scholar
• Lee H, Lee K, Kim IK, et al. Synthesis, characterization, and in vivo diagnostic applications of hyaluronic acid immobilized gold nanoprobes. Biomaterials. 2008;29:4709–4718.
   PubMed Web of Science ®Google Scholar
• Lutz JF, Stiller S, Hoth A, et al. One-pot synthesis of PEGylated ultrasmall iron-oxide nanoparticles and their in vivo evaluation as magnetic resonance imaging contrast agents. Biomacromolecules. 2006;7:3132–3138.
   PubMed Web of Science ®Google Scholar
• Akbarzadeh A, Zarghami N, Mikaeili H, et al. Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Nanotechnol Sci Appl. 2012;5:13–25.
   PubMedGoogle Scholar
• Dai F, Du M, Liu Y, et al. Folic acid-conjugated glucose and dextran coated iron oxide nanoparticles as MRI contrast agents for diagnosis and treatment response of rheumatoid arthritis. J Mater Chem B. 2014;2:2240–2247.
   PubMed Web of Science ®Google Scholar
• Arias JL, Ruiz MA, Gallardo V. Tegafur loading and release properties of magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles. J Control Release. 2008;125:50–58.
   PubMed Web of Science ®Google Scholar
• Ma X, Tao H, Yang K, et al. A functionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging. Nano Res. 2012;5:199–212.
   Web of Science ®Google Scholar
• Kim HJ, Lee SM, Park KH, et al. Drug-loaded gold/iron/gold plasmonic nanoparticles for magnetic targeted chemo-photothermal treatment of rheumatoid arthritis. Biomaterials. 2015;61:95–102.
   PubMed Web of Science ®Google Scholar
• Chen CL, Siow TY, Chou CH, et al. Targeted superparamagnetic iron oxide nanoparticles for in vivo magnetic resonance imaging of T-cells in rheumatoid arthritis. Mol Imaging Biol. 2017;19:233–244.
   PubMed Web of Science ®Google Scholar
• Periyathambi P, Sastry TP, Anandasadagopan SK, et al. Macrophages mediated diagnosis of rheumatoid arthritis using fibrin based magnetic nanoparticles as MRI contrast agents. Biochim Biophys Acta. 2017;1861:2992–3001.
   PubMed Web of Science ®Google Scholar
• Vimalnath KV, Chakraborty S, Rajeswari A. Formulation, characterization and bio-evaluation of Holmium-166 labeled agglomerated iron oxide nanoparticles for treatment of arthritis of knee joints. Mater Today. 2017;4:4329–4338.
   Google Scholar
• Radermacher KA, Beghein N, Boutry S. In vivo detection of inflammation using pegylated iron oxide particles targeted at E-selectin: a multimodal approach using MR imaging and EPR spectroscopy. Invest Radiol. 2009;44:398–404.
   PubMed Web of Science ®Google Scholar
• Fernandes JC, Wang H, Jreyssaty C. Bone-protective effects of nonviral gene therapy with folate–chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis. Mol Ther. 2008;16:1243–1251.
   PubMed Web of Science ®Google Scholar
• Fernandes JC, Qiu X, Winnik FM. Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies. Int J Nanomed. 2012;7:5833–5845.
   PubMed Web of Science ®Google Scholar
• Kim MJ, Park JS, Lee SJ. Notch1 targeting siRNA delivery nanoparticles for rheumatoid arthritis therapy. J Control Release. 2015;216:140–148.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Lee A, Hwang SR, et al. TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis. Mol Ther. 2014;22:397–408.
   PubMed Web of Science ®Google Scholar
• Zhou HF, Yan H, Pan H, et al. Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis. J Clin Invest. 2014;124:4363.
   PubMed Web of Science ®Google Scholar
• Jain S, Amiji M. Tuftsin-modified alginate nanoparticles as a noncondensing macrophage-targeted DNA delivery system. Biomacromolecules. 2012;13:1074–1085.
   PubMed Web of Science ®Google Scholar
• Komano Y, Yagi N, Onoue I. Arthritic joint-targeting small interfering RNA-encapsulated liposome: implication for treatment strategy for rheumatoid arthritis. J Pharmacol Exp Ther. 2012;340:109–113.
   PubMed Web of Science ®Google Scholar